Effects of Dopaminergic Agonists on Plasma Luteinizing Hormone - Releasing Hormone (LRH) and Gonadotropins in Man
Effects of Dopaminergic Agonists on Plasma Luteinizing Hormone - Releasing Hormone (LRH) and Gonadotropins in Man
复制标题
多巴胺能激动剂对人类血浆黄体生成素释放激素(LRH)和促性腺激素的影响
DOI:
--
复制
发表时间:
1987
期刊:
影响因子:
--
通讯作者:
K. Nakagawa
中科院分区:
文献类型:
--
作者:
M. Matsubara;M. Tango;K. Nakagawa
To try to determine the site and mode of action of dopamine (DA) on the secretion of gonadotropins in humans, 4 series of studies were performed in 19 healthy volunteers (7 healthy males, 5 females in follicular phase and 7 postmenopausal females). The intravenous infusion of DA at the rate of 4 micrograms/kg/min decreased plasma LH levels to 75.9 +/- 3.7 (mean +/- SE)% of the initial levels. The oral administration of 500 mg of levodopa (Dopa) also suppressed the concentration of plasma LH to 73.0 +/- 3.5%, but the pretreatment with two doses of 100 mg each of carbidopa (CD), a peripheral dopa decarboxylase inhibitor, attenuated this suppressing effect of Dopa on LH levels (nadir 82.4 +/- 4.1). Plasma FSH were not significantly altered by these drugs. On the other hand, the concentration of endogenous LRH in peripheral blood remained unchanged throughout the studies. The administration of CD alone had no effect on any of these 3 parameters. These results would suggest the direct suppressing effect of DA on pituitary gonadotrophs, although the modulation at the level of the hypothalamus also cannot be ruled out.